SCHEMBL16615305

SCHEMBL16615305

CC(c1c(Cl)ccc(F)c1Cl)N1CCNc2c1c1c(C(=O)Nc3cccc(C(=O)N4CCCC4)c3)n2-1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.40
NTRK1 P04629 2/20 0.40
TSHR P16473 1/20 0.40
MET P08581 4/20 0.39
RAB9A P51151 2/20 0.38
MAP4K2 Q12851 1/20 0.38
MAP3K1 Q13233 1/20 0.38
AAK1 Q2M2I8 1/20 0.38
Q6ZSR9 Q6ZSR9 1/20 0.38
MAP4K5 Q9Y4K4 1/20 0.38
HTT P42858 3/20 0.38
POLB P06746 2/20 0.38
KDM4E B2RXH2 1/20 0.38
TP53 P04637 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HPGD P15428 1/20 0.36
NPC1 O15118 1/20 0.36
MGLL Q99685 1/20 0.35
CBLB Q13191 2/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16615320 0.91 MET (0.45) KMT2ANTRK1METRAB9AMAP4K2
SCHEMBL17918667 0.81 MET (0.46) KMT2ANTRK1TSHRMETRAB9A
SCHEMBL20859431 0.77 KMT2A (0.39) KMT2ANTRK1TSHRMETRAB9A
SCHEMBL17918726 0.73 MET (0.54) KMT2ANTRK1METRAB9AMAP4K2
SCHEMBL16615215 0.72 ALK (0.50) KMT2ATSHRRAB9AHTTPOLB
SCHEMBL20859323 0.71 MET (0.44) KMT2ANTRK1METRAB9AMAP4K2
SCHEMBL16615268 0.71 KDM4E (0.41) RAB9AHTTPOLBKDM4ETP53
SCHEMBL17918666 0.70 MET (0.44) KMT2ANTRK1TSHRMETRAB9A
SCHEMBL17918857 0.68 MET (0.50) KMT2AMETRAB9AMAP4K2MAP3K1
SCHEMBL17969736 0.68 MET (0.43) KMT2AMETRAB9AMAP4K2MAP3K1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015047133-A1 NOVEL CHEMICAL COMPOUNDS (VARIANTS) AND THE USE THEREOF TO TREAT ONCOLOGICAL DISEASES ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "ОТЕЧЕСТВЕННЫЕ ФАРМАЦЕВТИЧЕСКИЕ ТЕХНОЛОГИИ" 2015-04-02 WO disclosed